Nasdaq:US$13.18 (-0.15) | HKEX:HK$20.30 (-0.52) | AIM:£2.00 (-0.01)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma